MADISON, Conn., Sept 18 /PRNewswire/ -- Further results from the initial clinical trial of the ClariVein(TM) catheter, used in a new minimally invasive treatment for varicose veins, will be delivered on Friday, September 25, at the 23rd Annual Meeting of the Eastern Vascular Society in Philadelphia. The device combines mechanical and chemical modalities to accomplish vein treatment in an in-office setting.
"Initial results were very encouraging, and the success rates continue to be excellent as we follow patients over a longer period," Dr. Elias states. "The success rates are equal to the early results of radiofrequency or laser treatment of great saphenous vein disease. The main advantage is that the technique does not require tumescence anesthesia infusion, thus saving significant time and decreasing patient discomfort. In addition, no generator is required and capital and maintenance cost is reduced. This in-office procedure takes about 15 minutes to perform and patients resume normal activity that day. All patients would recommend the procedure to others."
Dr. Elias is scheduled to speak at the 10:00 am scientific session at the Loews Philadelphia Hotel.
Vascular Insights LLC
